Diltiazem Hydrochloride
Diltiazem Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Diltiazem Hydrochloride; Generic name: DILTIAZEM HYDROCHLORIDE; Manufacturer: Alembic Pharmaceuticals Inc..
| Brand name | Diltiazem Hydrochloride |
|---|---|
| Generic name | DILTIAZEM HYDROCHLORIDE |
| Manufacturer | Alembic Pharmaceuticals Inc. |
| Used for | INDICATIONS AND USAGE Diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension. Diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics. Diltiazem hydrochloride extended-release capsules are indicated for the management of chronic stable angina. |
| Dosage | DOSAGE AND ADMINISTRATION Hypertensive or anginal patients who are treated with other formulations of diltiazem can safely be switched to diltiazem hydrochloride extended-release capsules at the nearest equivalent total daily dose. Subsequent titration to higher or lower doses may, however, be necessary and should be initiated as clinically indicated. Studies have shown a slight increase in the rate of absorption of diltiazem hydrochloride extended-release capsules when ingested with a high-fat |
| Warnings | WARNINGS Cardiac Conduction Diltiazem hydrochloride prolongs AV node refractory periods without significantly prolonging sinus node recovery time, except in patients with sick sinus syndrome. This effect may rarely result in abnormally slow heart rates (particularly in patients with sick sinus syndrome) or second, or third degree AV block (22 of 10,119 patients, or 0.2%); 41% of these 22 patients were receiving concomitant β-adrenoceptor antagonists versus 17% of the total group. Concomitant use |
| Active ingredient(s) | DILTIAZEM HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04a85be5-f746-418e-8e37-292703f16934 |